CompletedNCT01227980
Pexacerfont for Anxiety and Alcohol Craving
About this title
Read the official source — NCT01227980Medication studyAges 21–65United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateOctober 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 70
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT01227980
- Official title
Show the full official title
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Pexacerfont and Placebo.
Who was this study for?
Listed age limits: 21 years to 65 years.
